In a real-world study, dose reductions of an FDA-approved therapy for pancreatic cancer were effective and associated with improved clinical outcomes in the treatment of advanced disease.
Reduced-Dose Treatment is Effective Against Advanced Pancreatic Cancer
Jordan Litaker2021-02-10T13:13:43+00:00January 5th, 2021|Uncategorized|Comments Off on Reduced-Dose Treatment is Effective Against Advanced Pancreatic Cancer